News & Resources

How to Enhance Your Presence at Oncology Conferences

Are you gearing up for the next oncology conference? Promoting your services and products can be a competitive sport in the field of oncology.

The growing incidence of cancer all over the world has precipitated a renewed focus on oncology products within the pharmaceutical industry. In fact, there are over a thousand drugs in development just in this one category. When attending any number of oncology conferences, how can you get your message to stand out to stakeholders? Here are some tips on how to improve your company’s visibility.

Partner with the Right Marketing Experts
Partner with the right event-marketing experts. Look for an agency that specializes in medical communications with experience in marketing oncology products. The right agency will have a panel of clinical experts as well as team members who are well versed in the different sectors of the pharma industry. In fact, the top 20 pharma companies all partner with specialized marketing agencies to ensure an impactful presence and support at oncology conferences. The right communications agency not only offers proven experience in event marketing, but also has a host of other programs that enable continued engagement with stakeholders. These agencies understand that engagement begins before meeting at the oncology conferences, and continues long after. In fact, your stakeholder relationships should shape your marketing messages.

A Message That Meets Stakeholder Needs
Your presence at an oncology conference should communicate how you will meet the needs of the stakeholder, specifically stakeholders in products to eradicate cancer. This means you need to project your scientific, clinical, and commercial acumen about the marketplace and how your product fits in. Stakeholders demand a certain level of confidence that your product not only does what it is supposed to, but that it performs on multiple levels. Is your product amenable to good marketing strategies? Will it stand up under scrutiny of scientific communications and allow for continued clinical development? Will it find favor within medical affairs, including hospital consultants and key opinion leaders (KOLs)? When you engage stakeholders throughout your drug development and commercialization processes, you will receive specific insight that informs a more robust marketing strategy, benefiting both the product and stakeholders.

Be Business-Facing
For oncology conferences, your marketing message should be business-facing. The language and marketing approach should look to establish or grow a relationship based on shared business interests. It’s important to convey not only your knowledge of current market trends, but also your view of the market based on experience. The ability to look forward and know what makes good business sense, as well as what propels good medicine, is vital to attracting stakeholders. This is where an agency provider of medical insights provides a valuable leg up on the competition. An agency can fortify you with its full team of scientific, clinical, research, marketing, sales, and communications experts, all with extensive experience in the pharmaceutical industry and background in oncology.

Determine a Conference-Specific Message
Decide on a conference-specific goal for your messaging strategy. What are you trying to achieve by attending the oncology conference? While your strategy should first and foremost inspire stakeholder engagement, the specific message may change depending on the conference audience, location, and content. Your message may be to increase brand awareness, to build future relationships, or to establish your company as highly innovative or as an authority in your specific sector. Whatever the goal, your message should be consistent and focused. This will allow you to maximize the time and resources you spend at a conference. Consistency in marketing materials should include all of your print collateral, social media activity, and talking points used by all company attendees. To get the most out of your marketing strategy, you should recycle content for pre-conference marketing and post-conference follow-up. Remember, a stellar marketing strategy will strengthen your presence at any conference.

Maximize Visibility With Innovative Communications
Communication and education are crucial to your presence at oncology conferences. These can establish your expertise and educate stakeholders on your company’s proficiency at branding strategies. Make use of non-traditional and interactive approaches to communicate your message. Consider hosting a roundtable lunch or breakfast for conference attendees to drive a dialogue that supports your message. Project multimedia visuals at your booth: videos with 3D graphics and animation will draw attention to your finely-curated message. More and more, communication efforts are relying on technology-driven media to engage stakeholders, payers, care providers, and even patients. A dynamic tool that can be used to engage stakeholders at your booth is an e-book developed for an iPad. Using appealing graphic design, an e-book can visually represent data from a recent study that supports your message. A PDF of the e-book can then be emailed to the stakeholders, allowing you to capture their email for future engagement.

Use Social Media to Increase Your Presence
Using social media is a way to get your message out before the oncology conference and enables you to amplify your message during the conference. Getting involved in the conversation is vital to establishing your presence at oncology conferences. For one, you can use social media to literally announce your presence at the conference and the location of your booth. Using the official conference hashtag connects you to important conversations involving potential stakeholders. Pre-planning your social media content can be invaluable. You can schedule specific posts to be broadcast throughout the conference, and supplement these posts with live tweets that announce your involvement in conference events.

Affirm Your Commitment to Cancer Research
Your presence at the next oncology conference can be enhanced with a compelling booth presentation and social media skills, but it’s just as important to affirm your commitment to cancer research. Ask yourself why the stakeholders you engage are interested in your product specifically. Stakeholders attending oncology conferences have a deep interest in cancer research and are looking to fund products to eradicate cancer. Inspire confidence by expressing your company’s commitment to cancer research. You can do this by elucidating your expertise on the stages of drug development, evidence of supporting data on the clinical effects of your drug, the impact of pricing and its commercial potential, and consideration of how the drug will be made accessible to patients.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.